Chimeric Therapeutics Limited Share Price
Equities
CHM
AU0000121576
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | +11.11% |
|
+17.65% | -42.86% |
22/05 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
20/05 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.53M 10.35M 865M |
---|---|---|---|---|---|
Net income 2024 * | -13M -8.67M -724M | Net income 2025 * | -21M -14M -1.17B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
1 day | +11.11% | ||
1 week | +17.65% | ||
Current month | +11.11% | ||
1 month | -13.04% | ||
3 months | -37.50% | ||
6 months | -25.93% | ||
Current year | -42.86% |
![Extreme 0.017](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
![Extreme 0.016](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 12/23/12 |
Chief Tech/Sci/R&D Officer | - | 05/22/05 | |
Li Ren
CTO | Chief Tech/Sci/R&D Officer | - | 25/21/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lesley Russell
BRD | Director/Board Member | 63 | 28/20/28 |
Paul Hopper
FOU | Founder | 68 | 02/20/02 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 12/23/12 |
Date | Price | Change | Volume |
---|---|---|---|
21/24/21 | 0.02 | +11.11% | 2 603 970 |
20/24/20 | 0.018 | 0.00% | 951,378 |
19/24/19 | 0.018 | 0.00% | 1,114,395 |
18/24/18 | 0.018 | +5.88% | 787,399 |
17/24/17 | 0.017 | 0.00% | 2,646,076 |
Delayed Quote Australian S.E., June 21, 2024 at 10:36 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.86% | 10.34M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- CHM Stock